Monday, April 24, 2017
 
 
Company News: Page (1) of 1 - 02/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Study shows biocompatible 3D tracking system has potential to improve manual and robot-assisted surgery and interventions
 
(February 17, 2017)

WASHINGTON, Feb. 17, 2017 /PRNewswire-USNewswire/ -- The cutting-edge biocompatible near-infrared 3D tracking system used to guide the suturing in the first smart tissue autonomous robot (STAR) surgery has the potential to improve manual and robot-assisted surgery and interventions through unobstructed 3D visibility and enhanced accuracy, according to a study published in the March 2017 issue of IEEE Transactions on Biomedical Engineering. The study successfully demonstrates feasibility in live subjects (in-vivo) and demonstrates 3D tracking of tissue and surgical tools with millimeter accuracy in ex-vivo tests. More accurate and consistent suturing helps reduce leakage, which can improve surgical outcomes.

Authored by the development team from Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System and funded by the National Institutes of Health, the study explains the design of the 3D tracking system with near-infrared fluorescent (NIRF) markers and, using robotic experiments, compares its tracking accuracies against standard optical tracking methods. At speeds of 1 mm/second, the team observed tracking accuracies of 1.61 mm that degraded only to 1.71 mm when the markers were covered in blood and tissue.

"A fundamental challenge in soft-tissue surgery is that target tissue moves and deforms, becomes occluded by blood or other tissue, which makes it difficult to differentiate from surrounding tissue," says Axel Krieger, Ph.D., senior author on the study and program lead for Smart Tools at the Sheikh Zayed Institute. "By enabling accurate tracking of tools and tissue in the surgical environment, this innovative work has the potential to improve many applications for manual and robot-assisted surgery."


The system is made up of small biocompatible NIRF markers with a novel fused plenoptic and near-infrared (NIR) camera tracking system, enabling 3D tracking that can overcome blood and tissue occlusion in an uncontrolled, rapidly changing surgical environment. Krieger explains that the NIR imaging has the potential to overcome occlusion problems because NIR light penetrates deeper than visual light.

"This work describes the 'super human eyes' and a bit of 'intelligence' of our STAR robotic system, making tasks such as soft tissue surgery on live subjects possible," explains Peter C. Kim, M.D., vice president and associate surgeon in chief of the Sheikh Zayed Institute.

Future work will include further integration and evaluation of the tracking system in image-guided medical interventions such as robotic surgeries.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/study-shows-biocompatible-3d-tracking-system-has-potential-to-improve-manual-and-robot-assisted-surgery-and-interventions-300409510.html

SOURCE Children's National Health System

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Surgery, Surgery, Lifestyle, Other,
Related Sites: DMN Newswire ,   CEN - Consumer Electronics Net ,   CEN - Photography ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Kidney Dialysis Equipment Market to be Surpass US$ 24.5 Billion by 2024, On the Back of Increasing Prevalence of Chronic Kidney Diseases
  • Minimally Invasive Spine (MIS) Market Current and Future Players Products Pipeline Available in 2017 Report at ReportsnReports.com
  • Global Breast Biopsy Devices Market Expanding At A CAGR Of 10.6% From 2016 To 2022 - Credence Research
  • United States In Vitro Diagnostics Market Estimated to Grow at a CAGR of 4.9% from 2018 to 2023 - Axiom MRC.
  • Global Medical Imaging Software Market Driven by the Increasing Need for Early Diagnosis and Preventive Medicine: Technavio

    Cancer
  • Achillion Announces Additional Phase 2 Results Including 100% SVR24 for Genotype 1 HCV After 6-Weeks of Once Daily JNJ-4178
  • Tobacco Companies Gave $1.5 Million to Trump Inaugural and Ramped Up Lobbying - They Want to Roll Back FDA Oversight of E-Cigarettes, Cigars
  • Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins
  • Targeting Cancer Cells With an Implantable Drug Delivery System
  • Public Health Campaign Says Dollar General's Illegal Hazardous Waste Treatment is Another Example of Careless Corporate Behavior Endangering Communities
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines